[e-drug] Questions about bioequivalency

e-drug
1

E-DRUG: Questions about bioequivalency
---------------------------------------------------------

Dear e.druggers,
   
  I have these questions, please try to help me answer them:

  1) If we don't have the capacity to determine bioequivalency of generics, and we are not involved in mutual reognition with other countries, are there any alternatives ??
   
  2) Has anyone come across qualitative studies about generic uptake barriers in developing countries??
   
  Your comments and answers are most appreciated.
   
  Thank you very much
   
  Nabil AL-Gedadi
Studying at Universiti Sains Malaysia
Penang, Malaysia
"nabil gedadi" <gedadi1972@yahoo.com>

2

E-DRUG: WHO: Essential Medicines for Children - request for comments/input
-------------------------------------------------------------------
[To respond DO NOT CLICK REPLY. Respond at the website
http://mednet3.who.int/EML/expcom/CHILDREN/EMLc_AppForm.pdf
or to emlsecretariat@who.int ]

Hi all

As part of the follow-up to the Executive Board resolution EB.120.R13
(see http://www.who.int/gb/ebwha/pdf_files/EB120/B120_R13-en.pdf),

the WHO is holding an Expert Consultation on Essential Medicines for
Children in Geneva from 9 to 13 July 2007. The background to this
process was outlined in the Bulletin of the World Health Organisation,
Volume 85, Number 4, April 2007, 245-324
see
http://www.who.int/bulletin/volumes/85/4/07-010407/en/index.html

The first draft of a WHO Model List of Essential Medicines for Children
is now on the WHO website at
http://mednet3.who.int/EML/expcom/CHILDREN/INDEX_children_07.htm.

The site also contains the draft agenda and the policy papers and
applications received to date. Comments on the draft list can be
submitted before 31 May 2007.

Full applications for inclusion, change or deletion of a medicine in
the Model List of Essential Medicines for Children, using the format
specified on the meeting website

http://mednet3.who.int/EML/expcom/CHILDREN/EMLc_AppForm.pdf

should be sent to the Secretary of the Expert Consultation before 15 May 2007.

The address is:

The Secretary of the Expert Consultation on Essential Medicines for
Children
Policy, Access and Rational Use
Department of Medicines Policy and Standards
World Health Organization
20 Avenue Appia
CH-1211 Geneva 27
Switzerland
email: emlsecretariat@who.int

Public comments, including letters of support on the applications, may
also be submitted to emlsecretariat@who.int. All comments received will
be published on the web.

regards
Andy

Andy Gray MSc(Pharm) FPS
* Senior Lecturer
Dept of Therapeutics and Medicines Management
* Consultant Pharmacist
Centre for the AIDS Programme of Research
in South Africa (CAPRISA)
Nelson R Mandela School of Medicine
University of KwaZulu-Natal
PBag 7 Congella 4013
South Africa
Tel: +27-31-2604334/4298 Fax: +27-31-2604338
email: graya1@ukzn.ac.za or andy@gray.za.net